References
- StewartTLJinHMcGuiganFEHaplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in womenJ Clin Endocrinol Metab20069193575358316804049
- NguyenTVEismanJAPharmacogenomics of osteoporosis: opportunities and challengesJ Musculoskelet Neuronal Interact200661627216675890
- EismanJAPharmacogenetics of the vitamin D receptor and osteoporosisDrug Metab Dispos2001294 Pt 250551211259341
- NguyenTVCenterJREismanJAPharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapyCurr Opin Endocrinol Diabetes Obes200815648148818971675
- DealCPotential new drug targets for osteoporosisNat Clin Pract Rheum2009512027
- HardyBJSeguinBGoodsaidFJimenez-SanchezGSingerPADaarASThe next steps for genomic medicine: challenges and opportunities for the developing worldNat Rev Genet20089Suppl 1S23S2718802418
- SadeeWPharmacogenomicsWest J Med19991715–632833218751198
- HagaSBBurkeWPharmacogenetic testing: not as simple as it seemsGenet Med200810639139518496219
- FerrariSHuman genetics of osteoporosisBest Pract Res Clin Endocrinol Metab200822572373519028354
- ValdivielsoJMFernandezEVitamin D receptor polymorphisms and diseasesClin Chim Acta20063711–211216563362
- XiongDHLiuXGGuoYFGenome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groupsAm J Hum Genet200984338839819249006
- Horst-SikorskaWIgnaszak-SzczepaniakMMarcinkowskaMKaczmarekMStajgisMSlomskiRAssociation analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves’ diseaseActa Biochim Pol200855237138018506225
- HausslerMRHausslerCABartikLVitamin D receptor: molecular signaling and actions of nutritional ligands in disease preventionNutr Rev200866Suppl 2S98S11218844852
- OngphiphadhanakulBOsteoporosis: the role of genetics and the environmentForum Nutr20076015816717684412
- MassartFMarcucciGBrandiMLPharmacogenetics of bone treatments: the VDR and ERalpha gene storyPharmacogenomics20089673374618518851
- UitterlindenAGRalstonSHBrandiMLThe association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysisAnn Intern Med2006145425526416908916
- PalombaSNumisFGMossettiGEffectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypesClin Endocrinol (Oxf)200358336537112608943
- PalombaSNumisFGMossettiGRaloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypesHum Reprod200318119219812525466
- OngphiphadhanakulBRajatanavinRChanprasertyothinSVitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal womenJ Endocrinol Invest199720105925969438916
- Dawson-HughesBHarrisSSFinneranSCalcium absorption on high and low calcium intakes in relation to vitamin D receptor genotypeJ Clin Endocrinol Metab19958012365736618530616
- Horst-SikorskaWKalakRWawrzyniakAMarcinkowskaMCelczynska-BajewLSlomskiRAssociation analysis of the polymorphisms of the VDR gene with bone mineral density and the occurrence of fracturesJ Bone Miner Metab200725531031917704996
- BandresEPomboIGonzalez-HuarrizMRebolloALopezGGarcia-FoncillasJAssociation between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal womenJ Endocrinol Invest200528431232115966503
- MorrisonNAGeorgePMVaughanTTilyardMWFramptonCMGilchristNLVitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosisPharmacogenet Genomics200515212713515861036
- UysalARSahinMGursoyAGulluSVitamin D receptor gene polymorphism and osteoporosis in the Turkish populationGenet Test200812459159418976159
- UitterlindenAGFangYBerginkAPvan MeursJBvan LeeuwenHPPolsHAThe role of vitamin D receptor gene polymorphisms in bone biologyMol Cell Endocrinol20021971–2152112431791
- EcksteinMVeredIIsh-ShalomSVitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral densityIsr Med Assoc J20024534034412040821
- Al-oanziZHTuckSPMastanaSSVitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in menOsteoporos Int200819795196018038108
- ThijssenJHGene polymorphisms involved in the regulation of bone qualityGynecol Endocrinol200622313113916835074
- XiongDHLongJRReckerRRDengHWPharmacogenomic approaches to osteoporosisPharmacogenomics J20033526126314583795
- IoannidisJPStavrouITrikalinosTAAssociation of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysisJ Bone Miner Res200217112048206012412813
- IoannidisJPRalstonSHBennettSTDifferential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomesJAMA2004292172105211415523071
- WilliamsFMSpectorTDThe genetics of osteoporosisActa Reumatol Port200732323124017940498
- SalmenTHeikkinenAMMahonenAThe protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal womenJ Bone Miner Res200015122479248611127213
- OngphiphadhanakulBChanprasertyothinSPayatikulPOestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal womenClin Endocrinol (Oxf)200052558158510792337
- ShearmanAMKarasikDGruenthalKMEstrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham StudyJ Bone Miner Res200419577378115068501
- UitterlindenAGBurgerHHuangQRelation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal womenN Engl J Med199833815101610219535665
- MannVHobsonEELiBA COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and qualityJ Clin Invest2001107789990711285309
- RalstonSHUitterlindenAGBrandiMLLarge-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS studyPLoS Med200634e9016475872
- QureshiAMHerdRJBlakeGMFogelmanIRalstonSHCOLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapyCalcif Tissue Int200270315816311907712
- HustedLBHarslofTGonzalez-BofillNHaplotypes of promoter and intron 1 polymorphisms in the COLIA1 gene are associated with increased risk of osteoporosisCalcif Tissue Int2009842859619082910
- RianchoJAPolymorphisms in the CYP19 gene that influence bone mineral densityPharmacogenomics20078433935217391072
- DickIMDevineAPrinceRLAssociation of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older womenAm J Physiol Endocrinol Metab20052885E989E99515613678
- ZarrabeitiaAZarrabeitiaMTValeroCGonzalez-MaciasJRianchoJAAge-related influence of common aromatase gene polymorphisms on bone mass of healthy menBone200435124324815207764
- YoungRWuFVan de WaterNAmesRGambleGReidIRCalcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal womenJ Clin Endocrinol Metab200388269770012574201
- TakacsISpeerGBajnokELack of association between calcium-sensing receptor gene “A986S” polymorphism and bone mineral density in Hungarian postmenopausal womenBone200230684985212052452
- van MeursJBTrikalinosTARalstonSHGENOMOS StudyLarge-scale analysis of association between LRP5 and LRP6 variants and osteoporosisJAMA2008299111277129018349089
- International HapMap ConsortiumThe International HapMap ProjectNature2003426696878979614685227
- FerrariSLGarneroPEmondSMontgomeryHHumphriesSEGreenspanSLA functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal womenArthritis Rheum200144119620111212160
- FerrariSLKarasikDLiuJInteractions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis StudyJ Bone Miner Res200419455255915005841
- KimJGChoiYMMoonSYLeeJYAssociation of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean womenMenopause200310654454914627864
- ToftengCLKindmarkABrändströmHDanish Osteoporosis Prevention StudyPolymorphisms in the CYP19 and AR genes – relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention StudyCalcif Tissue Int2004741253414517714
- OhlendorffSDToftengCLJensenJESingle nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatmentPharmacogenet Genomics200717755556717558311
- McLeanRRKarasikDSelhubJAssociation of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate statusJ Bone Miner Res200419341041815040829
- ToftengCLBach-MortensenPBojesenSETybjaerg-HansenAHyldstrupLNordestgaardBGIntegrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general populationPharmacogenet Genomics2007171859117264806